File photo: Jim Watson of AFP/Getty Images
The funding will be used to develop Affinivax’s Multiple Antigen Presenting System (MAPS) technology platform and enable the development of vaccines to protect children and adults in the developed and developing worlds, with an initial focus on Streptococcus pneumoniae.
“It is unacceptable that pneumonia remains the leading cause of death among children under 5,” said Trevor Mundel, president of the global health unit at the Gates Foundation.
The company has also secured an exclusive license from Boston Children’s Hospital for intellectual property related to MAPS. The platform was initially developed at Children’s by Dr. Richard Malley, Affinivax’s scientific founder.
Bill Gates has backed Boston-area companies before. One of his investments was in Foundation Medicine, a Cambridge company that specializes in genomic testing for cancer patients.
Bill Gates is the cofounder and former chief executive of Microsoft Corp.
MetLife, Enterprise car rentals, airlines, and Boston home security startup SimpliSafe dropped NRA deals after the Parkland shooting.Continue reading »
Many of the employees have worked for Partners for several years, or even decades.Continue reading »
The relocation comes after the hospital chain expanded significantly outside of Massachusetts.Continue reading »
With the private sector reluctant, would a state bank make it easier to collect cannabis taxes and prevent theft?Continue reading »
Legal uncertainty may force banks to pass on financing marijuana industry in Massachusetts.Continue reading »
Peter Hotton answers readers’ questions.Continue reading »
Inflation can stimulate spending and make it easier for the Fed to tackle a recession.Continue reading »
A look at the most reviewed attractions in each of the six New England states, and what visitors had to say about them.Continue reading »
The rates were approved Thursday by the Massachusetts Group Insurance Commission.Continue reading »